The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Pulmonary Hypertension in Chronic Lung Diseases
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
Ghofrani, H.-A., D'Armini, A. M., Grimminger, F., Hoeper, M. M., Jansa, P., Kim, N. H., Mayer, E., Simonneau, G., Wilkins, M. R., Fritsch, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209657 · Cited by 1,401
Self-citationRiociguat for the treatment of pulmonary arterial hypertension
Ghofrani, H.-A., Galiè, N., Grimminger, F., Grünig, E., Humbert, M., Jing, Z.-C., Keogh, A. M., Langleben, D., Kilama, M. O., Fritsch, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209655 · Cited by 1,346
Self-citationCombined pulmonary fibrosis and emphysema: a distinct underrecognised entity
Cottin, V., Nunes, H., Brillet, P.-Y., Delaval, P., Devouassoux, G., Tillie-Leblond, I., Israel-Biet, D., Court-Fortune, I., Valeyre, D., & Cordier, J.-F. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00021005 · Cited by 1,004
Self-citationEchocardiographic Assessment of Pulmonary Hypertension in Patients with Advanced Lung Disease
Arcasoy, S. M., Christie, J. D., Ferrari, V. A., Sutton, M. S. J., Zisman, D. A., Blumenthal, N. P., Pochettino, A., & Kotloff, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1130oc · Cited by 906
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Lettieri, C. J., Nathan, S. D., Barnett, S. D., Ahmad, S., & Shorr, A. F. (2006) · Chest · doi:10.1378/chest.129.3.746 · Cited by 879
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
Ghofrani, H. A., Wiedemann, R., Rose, F., Schermuly, R. T., Olschewski, H., Weissmann, N., Gunther, A., Walmrath, D., Seeger, W., & Grimminger, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11024-5 · Cited by 769
Self-citationBUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
King, T. E., Brown, K. K., Raghu, G., du Bois, R. M., Lynch, D. A., Martinez, F., Valeyre, D., Leconte, I., Morganti, A., Roux, S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1874oc · Cited by 718
Severe Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Chaouat, A., Bugnet, A.-S., Kadaoui, N., Schott, R., Enache, I., Ducoloné, A., Ehrhart, M., Kessler, R., & Weitzenblum, E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-006oc · Cited by 714
Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era
Condliffe, R., Kiely, D. G., Peacock, A. J., Corris, P. A., Gibbs, J. S. R., Vrapi, F., Das, C., Elliot, C. A., Johnson, M., DeSoyza, J., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200806-953oc · Cited by 657
Self-citationA Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002110 · Cited by 634 · cited 1×
“However, vasodilators may preferentially access the better ventilated and oxygenated areas of the fibrotic lung because of their mode of distribution (inhaled iloprost, treprostinil, or nitric oxide [35,37,47]) or may enhance normoxic vasodilation (the phosphodiesterase 5 inhibitor sildenafil [36,48]), which may be ad…”
BackgroundExtracorporeal Membrane Oxygenation in Awake Patients as Bridge to Lung Transplantation
Fuehner, T., Kuehn, C., Hadem, J., Wiesner, O., Gottlieb, J., Tudorache, I., Olsson, K. M., Greer, M., Sommer, W., Welte, T., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201109-1599oc · Cited by 601
Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan: A Parallel, Randomized Trial
Raghu, G., Behr, J., Brown, K. K., Egan, J. J., Kawut, S. M., Flaherty, K. R., Martinez, F. J., Nathan, S. D., Wells, A. U., Collard, H. R., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-9-201305070-00003 · Cited by 553
Self-citationPrognostic Factors in COPD Patients Receiving Long-term Oxygen Therapy
Oswald-Mammosser, M., Weitzenblum, E., Quoix, E., Moser, G., Chaouat, A., Charpentier, C., & Kessler, R. (1995) · Chest · doi:10.1378/chest.107.5.1193 · Cited by 523
Clinical features of paediatric pulmonary hypertension: a registry study
Berger, R. M., Beghetti, M., Humpl, T., Raskob, G. E., Ivy, D. D., Jing, Z.-C., Bonnet, D., Schulze-Neick, I., & Barst, R. J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61621-8 · Cited by 508
BUILD-1: A Randomized Placebo-controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
King, T. E., Behr, J., Brown, K. K., du Bois, R. M., Lancaster, L., de Andrade, J. A., Stähler, G., Leconte, I., Roux, S., & Raghu, G. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-732oc · Cited by 500
Pulmonary Arterial Enlargement and Acute Exacerbations of COPD
Wells, J. M., Washko, G. R., Han, M. K., Abbas, N., Nath, H., Mamary, A. J., Regan, E., Bailey, W. C., Martinez, F. J., Westfall, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203830 · Cited by 499
Self-citationPulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
Cottin, V., Le Pavec, J., Prévot, G., Mal, H., Humbert, M., Simonneau, G., Cordier, J.-F., & GERM“O”P (2010) · European Respiratory Journal · doi:10.1183/09031936.00038709 · Cited by 478
Self-citationIdiopathic Pulmonary Fibrosis and Emphysema
Mejía, M., Carrillo, G., Rojas-Serrano, J., Estrada, A., Suárez, T., Alonso, D., Barrientos, E., Gaxiola, M., Navarro, C., & Selman, M. (2009) · Chest · doi:10.1378/chest.08-2306 · Cited by 468
Weitzenblum, E., Sautegeau, A., Ehrhart, M., Mammosser, M., & Pelletier, A. (1985) · American Review of Respiratory Disease · doi:10.1164/arrd.1985.131.4.493 · Cited by 461
Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis
Nunes, H. (2005) · Thorax · doi:10.1136/thx.2005.042838 · Cited by 420
Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung Fibrosis
OLSCHEWSKI, H., ARDESCHIR GHOFRANI, H., WALMRATH, D., SCHERMULY, R., TEMMESFELD-WOLLBRÜCK, B., GRIMMINGER, F., & SEEGER, W. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9810008 · Cited by 410
Self-citationHamada, K., Nagai, S., Tanaka, S., Handa, T., Shigematsu, M., Nagao, T., Mishima, M., Kitaichi, M., & Izumi, T. (2007) · Chest · doi:10.1378/chest.06-1466 · Cited by 390
Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
Shorr, A. F., Wainright, J. L., Cors, C. S., Lettieri, C. J., & Nathan, S. D. (2007) · European Respiratory Journal · doi:10.1183/09031936.00107206 · Cited by 377
A randomised, controlled trial of bosentan in severe COPD
Stolz, D., Rasch, H., Linka, A., Di Valentino, M., Meyer, A., Brutsche, M., & Tamm, M. (2008) · European Respiratory Journal · doi:10.1183/09031936.00011308 · Cited by 356
Blanco, I., Gimeno, E., Munoz, P. A., Pizarro, S., Gistau, C., Rodriguez-Roisin, R., Roca, J., & Barberà, J. A. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200907-0988oc · Cited by 292
Self-citationPulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics: Table. 1—
Shorr, A. F., Helman, D. L., Davies, D. B., & Nathan, S. D. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00083404 · Cited by 290
Brain Natriuretic Peptide Is a Prognostic Parameter in Chronic Lung Disease
Leuchte, H. H., Baumgartner, R. A., Nounou, M. E., Vogeser, M., Neurohr, C., Trautnitz, M., & Behr, J. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1545oc · Cited by 284
Incidence of Pulmonary Hypertension and Its Clinical Relevance in Patients With Sarcoidosis
Handa, T., Nagai, S., Miki, S., Fushimi, Y., Ohta, K., Mishima, M., & Izumi, T. (2006) · Chest · doi:10.1378/chest.129.5.1246 · Cited by 270
Andersen, K. H., Iversen, M., Kjaergaard, J., Mortensen, J., Nielsen-Kudsk, J. E., Bendstrup, E., Videbaek, R., & Carlsen, J. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2011.11.020 · Cited by 267
Pulmonary hypertension in interstitial lung disease: Fig. 1—
Behr, J., & Ryu, J. H. (2008) · European Respiratory Journal · doi:10.1183/09031936.00171307 · Cited by 263
Sildenafil Improves Walk Distance in Idiopathic Pulmonary Fibrosis
Collard, H. R., Anstrom, K. J., Schwarz, M. I., & Zisman, D. A. (2007) · Chest · doi:10.1378/chest.06-2101 · Cited by 254
Grimminger, F., Weimann, G., Frey, R., Voswinckel, R., Thamm, M., Bölkow, D., Weissmann, N., Mück, W., Unger, S., Wensing, G., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00039808 · Cited by 249
Ghofrani, H. A., Hoeper, M. M., Halank, M., Meyer, F. J., Staehler, G., Behr, J., Ewert, R., Weimann, G., & Grimminger, F. (2010) · European Respiratory Journal · doi:10.1183/09031936.00182909 · Cited by 240
Serial Development of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
Nathan, S. D., Shlobin, O. A., Ahmad, S., Koch, J., Barnett, S. D., Ad, N., Burton, N., & Leslie, K. (2008) · Respiration · doi:10.1159/000114246 · Cited by 227
Han, M. K., Bach, D. S., Hagan, P. G., Yow, E., Flaherty, K. R., Toews, G. B., Anstrom, K. J., & Martinez, F. J. (2013) · Chest · doi:10.1378/chest.12-1594 · Cited by 227
Self-citationDumitrascu, R., Weissmann, N., Ghofrani, H. A., Dony, E., Beuerlein, K., Schmidt, H., Stasch, J.-P., Gnoth, M. J., Seeger, W., Grimminger, F., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.581405 · Cited by 224
Self-citationKimura, M., Taniguchi, H., Kondoh, Y., Kimura, T., Kataoka, K., Nishiyama, O., Aso, H., Sakamoto, K., & Hasegawa, Y. (2013) · Respiration · doi:10.1159/000345221 · Cited by 222
Estimating pulmonary artery pressures by echocardiography in patients with emphysema
Fisher, M. R., Criner, G. J., Fishman, A. P., Hassoun, P. M., Minai, O. A., Scharf, S. M., & Fessler, A. H. E. (2007) · European Respiratory Journal · doi:10.1183/09031936.00033007 · Cited by 217
Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial
Blanco, I., Santos, S., Gea, J., Güell, R., Torres, F., Gimeno-Santos, E., Rodriguez, D. A., Vilaró, J., Gómez, B., Roca, J., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00176312 · Cited by 185
Self-citationLong-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease.
Weitzenblum, E., Sautegeau, A., Ehrhart, M., Mammosser, M., Hirth, C., & Roegel, E. (1984) · PubMed · doi:10.1164/arrd.1984.130.6.993 · Cited by 170
Treatment of Sarcoidosis-Associated Pulmonary Hypertension
Barnett, C. F., Bonura, E. J., Nathan, S. D., Ahmad, S., Shlobin, O. A., Osei, K., Zaiman, A. L., Hassoun, P. M., Moller, D. R., Barnett, S. D., et al. (2009) · Chest · doi:10.1378/chest.08-1881 · Cited by 161
Peripheral airway obstruction in primary pulmonary hypertension
Meyer, F. J. (2002) · Thorax · doi:10.1136/thorax.57.6.473 · Cited by 158
Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial
Hoeper, M. M., Halank, M., Wilkens, H., Günther, A., Weimann, G., Gebert, I., Leuchte, H. H., & Behr, J. (2012) · European Respiratory Journal · doi:10.1183/09031936.00213911 · Cited by 151
Effect of bosentan upon pulmonary hypertension in chronic obstructive pulmonary disease
Valerio, G., Bracciale, P., & D'Agostino, A. G. (2009) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465808103499 · Cited by 147
Ventilatory and Cardiocirculatory Exercise Profiles in COPD
Boerrigter, B. G., Bogaard, H. J., Trip, P., Groepenhoff, H., Rietema, H., Holverda, S., Boonstra, A., Postmus, P. E., Westerhof, N., & Noordegraaf, A. V. (2012) · CHEST Journal · doi:10.1378/chest.11-2798 · Cited by 145
Sildenafil treatment in COPD does not affect stroke volume or exercise capacity
Rietema, H., Holverda, S., Bogaard, H. J., Marcus, J. T., Smit, H. J., Westerhof, N., Postmus, P. E., Boonstra, A., & Noordegraaf, A. V. (2007) · European Respiratory Journal · doi:10.1183/09031936.00114207 · Cited by 140
Pulmonary Hypertension in Sarcoidosis
Baughman, R. P., Engel, P. J., & Nathan, S. D. (2015) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2015.08.011 · Cited by 137
Obesity and Pulmonary Hypertension: A Review of Pathophysiologic Mechanisms
Friedman, S. E., & Andrus, B. W. (2012) · Journal of Obesity · doi:10.1155/2012/505274 · Cited by 135
Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
Barberà, J. A., & Blanco, I. (2009) · Drugs · doi:10.2165/00003495-200969090-00002 · Cited by 132
Self-citationPavec, J. L., Girgis, R. E., Lechtzin, N., Mathai, S. C., Launay, D., Hummers, L. K., Zaiman, A., Sitbon, O., Simonneau, G., Humbert, M. J. C., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30423 · Cited by 132
Self-citationPrediction of pulmonary hypertension in idiopathic pulmonary fibrosis
Zisman, D. A., Ross, D. J., Belperio, J. A., Saggar, R., Lynch, J. P., Ardehali, A. A., & Karlamangla, A. S. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.05.012 · Cited by 127
Pulmonary Langerhans Cell Histiocytosis-Associated Pulmonary Hypertension
Pavec, J. L., Lorillon, G., Jaïs, X., Tchérakian, C., Feuillet, S., Dorfmüller, P., Simonneau, G., Humbert, M. J. C., & Tazi, A. (2012) · CHEST Journal · doi:10.1378/chest.11-2490 · Cited by 124
Self-citationInhaled iloprost for sarcoidosis associated pulmonary hypertension.
Baughman, R. P., Judson, M. A., Lower, E. E., Highland, K. B., Kwon, S. W., Craft, N., & Engel, P. J. (2009) · PubMed · Cited by 115
Nitric Oxide Inhalation During Exercise in Chronic Obstructive Pulmonary Disease
Roger, N., Barberà, J. A., Roca, J., Rovira, I., Gómez, F. P., & Rodriguez‐Roisin, R. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.3.9611051 · Cited by 104
Self-citationSildenafil for Chronic Obstructive Pulmonary Disease: A Randomized Crossover Trial
Lederer, D. J., Bartels, M. N., Schluger, N. W., Brogan, F., Jellen, P. A., Thomashow, B. M., & Kawut, S. M. (2012) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2011.651180 · Cited by 103
Wrobel, J. P., Thompson, B. R., & Williams, T. J. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.02.029 · Cited by 101
Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients
Cottin, V., Harari, S. A., Humbert, M. J. C., Mal, H., Dorfmüller, P., Jaïs, X., Reynaud‐Gaubert, M., Prévôt, G., Lazor, R., Taillé, C., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00093111 · Cited by 95
Self-citationManagement of end-stage sarcoidosis: pulmonary hypertension and lung transplantation
Shlobin, O. A., & Nathan, S. D. (2012) · European Respiratory Journal · doi:10.1183/09031936.00175511 · Cited by 93
Carlsen, J., Andersen, K. H., Boesgaard, S., Iversen, M., Steinbrüchel, D. A., & Andersen, C. B. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.11.014 · Cited by 92
Exercise capacity in idiopathic pulmonary fibrosis: The effect of pulmonary hypertension
Boutou, A., Pitsiou, G., TRIGONIS, I., Papakosta, D., Kontou, P., Chavouzis, N., Nakou, C., Argyropoulou, P., Wasserman, K., & Stanopoulos, I. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01909.x · Cited by 87
Safety and tolerability of bosentan in idiopathic pulmonary fibrosis: an open label study
Günther, A., Enke, B., Markart, P., Hammerl, P., Morr, H., Behr, J., Stähler, G., Seeger, W., Grimminger, F., Leconte, I., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00149205 · Cited by 80
Self-citationCottin, V. (2013) · BMC Research Notes · doi:10.1186/1756-0500-6-s1-s2 · Cited by 79
Self-citationSingh, S., Singh, V. P., Rao, R. S., et al. (2022) · The Indian Journal of Chest Diseases and Allied Sciences · doi:10.5005/ijcdas-53-2-81 · Cited by 77
Hoeper, M. M., Andreas, S., Bastian, A., Claussen, M., Ghofrani, H. A., Gorenflo, M., Grohé, C., Günther, A., Halank, M., Hammerl, P., et al. (2011) · International Journal of Cardiology · doi:10.1016/s0167-5273(11)70492-2 · Cited by 77
Pulmonary hypertension in idiopathic pulmonary fibrosis: a review.
Corte, T. J., Wort, S. J., & Wells, A. U. (2009) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 73
Self-citationElevated brain natriuretic peptide predicts mortality in interstitial lung disease
Corte, T. J., Wort, S. J., Gatzoulis, M. Α., Engel, R., Giannakoulas, G. A., Macdonald, P. M., & Wells, A. U. (2010) · European Respiratory Journal · doi:10.1183/09031936.00173509 · Cited by 68
Self-citationDobarro, D., Schreiber, B. E., Handler, C. E., Beynon, H., Denton, C. P., & Coghlan, G. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.09.031 · Cited by 66
Restrictive Ventilatory Pattern in Precapillary Pulmonary Hypertension
Horn, M., Ries, A. L., Neveu, C., & Moser, K. Μ. (1983) · American Review of Respiratory Disease · doi:10.1164/arrd.1983.128.1.163 · Cited by 58
Pulmonary function in advanced pulmonary hypertension.
Burke, C. M., Glanville, A. R., Morris, A., Rubin, D. L., Harvey, J. A., Theodore, J., & Robin, E. D. (1987) · Thorax · doi:10.1136/thx.42.2.131 · Cited by 56
Effects of inhaled nitric oxide at rest and during exercise in idiopathic pulmonary fibrosis
Blanco, I., Ribas, J., Xaubet, A., Gómez, F. P., Roca, J., Rodriguez‐Roisin, R., & Barberà, J. A. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01104.2010 · Cited by 54
Self-citationPulmonary hypertension in sarcoidosis
Avdeev, S. N. (2017) · PULMONOLOGIYA · doi:10.18093/0869-0189-2016-26-6-725-735 · Cited by 37
The National Emphysema Treatment Trial (NETT): A Study in Agency Collaboration
Weinmann, G. G., Chiang, Y.-P., & Sheingold, S. H. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200709-154et · Cited by 31
Manika, Κ., Pitsiou, G., Boutou, A., Tsaoussis, V., Chavouzis, N., Antoniou, M., Fotoulaki, M., Stanopoulos, I., & Kioumis, I. P. (2012) · Pulmonary Medicine · doi:10.1155/2012/252345 · Cited by 27
Ghofrani, H. A., Galiè, N., Grimminger, F., et al. (2012) · CHEST Journal · doi:10.1378/chest.1462799 · Cited by 26
Self-citation
Cited by
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationUpdated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationGaliè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationPulmonary arterial hypertension: pathogenesis and clinical management
Thenappan, T., Ormiston, M. L., Ryan, J. J., & Archer, S. L. (2018) · BMJ · doi:10.1136/bmj.j5492 · Cited by 998
Pulmonary hypertension in chronic lung disease and hypoxia
Nathan, S. D., Barbera, J. A., Gaine, S. P., Harari, S., Martinez, F. J., Olschewski, H., Olsson, K. M., Peacock, A. J., Pepke-Zaba, J., Provencher, S., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01914-2018 · Cited by 757
Self-citation
Metadata
- Authors
- Seeger, W., Adir, Y., Barberà, J. A., Champion, H., Coghlan, J. G., Cottin, V., De Marco, T., Galiè, N., Ghio, S., Gibbs, S., Martinez, F. J., Semigran, M. J., Simonneau, G., Wells, A. U., & Vachiéry, J.-L.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 62
- Issue
- 25
- Pages
- D109-D116
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2139036888
- Cited by
- 673
- References
- 74
- FWCI
- 41.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.